These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 23467980)

  • 21. Outcomes in Living Donor Compared With Deceased Donor Primary Liver Transplantation in Lower Acuity Patients With Model for End-Stage Liver Disease Scores <30.
    Kitajima T; Moonka D; Yeddula S; Collins K; Rizzari M; Yoshida A; Abouljoud MS; Nagai S
    Liver Transpl; 2021 Jul; 27(7):971-983. PubMed ID: 33492764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left lobe living donor liver transplantation in adults: What is the safety limit?
    Ikegami T; Yoshizumi T; Sakata K; Uchiyama H; Harimoto N; Harada N; Itoh S; Nagatsu A; Soejima Y; Maehara Y
    Liver Transpl; 2016 Dec; 22(12):1666-1675. PubMed ID: 27540888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. D-MELD as a predictor of early graft mortality in adult-to-adult living-donor liver transplantation.
    Ikegami T; Imai D; Wang H; Yoshizumi T; Yamashita Y; Ninomiya M; Iguchi T; Bekki Y; Shirabe K; Maehara Y
    Transplantation; 2014 Feb; 97(4):457-62. PubMed ID: 24531822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increasing practice and acceptable outcomes of high-MELD living donor liver transplantation in the USA.
    Anouti A; Patel MS; VanWagner LB; Lee WM; Asrani SK; Mufti AR; Rich NE; Vagefi PA; Shah JA; Kerr TA; Pedersen M; Hanish S; Singal AG; Cotter TG
    Liver Transpl; 2024 Jan; 30(1):72-82. PubMed ID: 37490432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.
    Terrault NA; Shiffman ML; Lok AS; Saab S; Tong L; Brown RS; Everson GT; Reddy KR; Fair JH; Kulik LM; Pruett TL; Seeff LB;
    Liver Transpl; 2007 Jan; 13(1):122-9. PubMed ID: 17192908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Different Scoring Systems Based on Both Donor and Recipient Characteristics for Predicting Outcome after Living Donor Liver Transplantation.
    Ma Y; Wang Q; Yang J; Yan L
    PLoS One; 2015; 10(9):e0136604. PubMed ID: 26378786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Right lobe living donors ages 55 years old and older in liver transplantation.
    Kim SH; Lee EC; Shim JR; Park SJ
    Liver Transpl; 2017 Oct; 23(10):1305-1311. PubMed ID: 28734130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome of Hepatitis B Virus Infection After Living-Donor Liver Transplant: A Single-center Experience Over 20 Years.
    Nafady-Hego H; Elgendy H; Nafady A; Uemoto S
    Exp Clin Transplant; 2016 Apr; 14(2):207-14. PubMed ID: 26867537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival Outcomes in Split Compared With Whole Liver Transplantation.
    Chul Yoon K; Song S; Jwa EK; Lee S; Man Kim J; Kim OK; Kyun Hong S; Yi NJ; Lee KW; Soo Kim M; Hwang S; Suh KS; Lee SK
    Liver Transpl; 2018 Oct; 24(10):1411-1424. PubMed ID: 29747216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome of using small-for-size grafts in living donor liver transplantation recipients with high model for end-stage liver disease scores: a single center experience.
    Li H; Li B; Wei Y; Yan L; Wen T; Xu M; Wang W; Yang J
    PLoS One; 2013; 8(9):e74081. PubMed ID: 24040171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of Proper Graft Selection in Adult Living-Donor Liver Transplant Recipients with Preoperative Deteriorated Condition.
    Iida T; Masuda K; Matsuyama T; Harada S; Nakamura T; Koshino K; Suzuki T; Nobori S; Ushogome H; Ito T; Sakamoto S; Uryuhara K; Okajima H; Kaihara S; Uemoto S; Yoshimura N
    Ann Transplant; 2017 Sep; 22():541-549. PubMed ID: 28883387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Graft-to-recipient weight ratio threshold adjusted to the model for end-stage liver disease score for living donor liver transplantation.
    Alim A; Erdogan Y; Yuzer Y; Tokat Y; Oezcelik A
    Liver Transpl; 2016 Dec; 22(12):1643-1648. PubMed ID: 27509534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Posttransplant mortality risk assessment for adult-to-adult right-lobe living donor liver recipients with benign end-stage liver disease.
    Zhang M; Yin F; Chen B; Li Y; Yan L; Wen T; Li B
    Scand J Gastroenterol; 2012 Jul; 47(7):842-52. PubMed ID: 22546008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Which recipient pretransplant factors, such as MELD, renal function, sarcopenia, and recent sepsis influence suitability for and outcome after living donor liver transplantation? A systematic review of the literature and expert panel recommendations.
    Roll GR; Spiro M; Raptis DA; Jalal A; Yan CT; Olthoff KM; Caicedo JC; Lee KW; Yagi S; Cattral MS; Soin AS;
    Clin Transplant; 2022 Oct; 36(10):e14656. PubMed ID: 35340054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival Benefit of Living-Donor Liver Transplant.
    Jackson WE; Malamon JS; Kaplan B; Saben JL; Schold JD; Pomposelli JJ; Pomfret EA
    JAMA Surg; 2022 Oct; 157(10):926-932. PubMed ID: 35921119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A high model for end-stage liver disease score should not be considered a contraindication to living donor liver transplantation.
    Poon KS; Chen TH; Jeng LB; Yang HR; Li PC; Lee CC; Yeh CC; Lai HC; Su WP; Peng CY; Chen YF; Ho YJ; Tsai PP
    Transplant Proc; 2012 Mar; 44(2):316-9. PubMed ID: 22410005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of patients with benign liver diseases undergoing living donor versus deceased donor liver transplantation.
    Li C; Mi K; Wen Tf; Yan Ln; Li B; Yang Jy; Xu Mq; Wang Wt; Wei Yg
    PLoS One; 2011; 6(11):e27366. PubMed ID: 22087299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of postoperative Model for End-Stage Liver Disease scoring system for evaluating liver graft function after living donor liver transplantation.
    Toshima T; Ikegami T; Kimura K; Harimoto N; Yamashita Y; Yoshizumi T; Soejima Y; Ikeda T; Shirabe K; Maehara Y
    Transplant Proc; 2014; 46(1):81-6. PubMed ID: 24507030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in China.
    Lei M; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG
    World J Gastroenterol; 2018 Dec; 24(48):5525-5536. PubMed ID: 30622380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.